GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kuvatris Therapeutics PXMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Kuvatris Therapeutics

Our reporting

We have not reported on Kuvatris Therapeutics yet.

Next results

2 Dec 2026

Due on 2 Dec 2026. Analysts expect earnings of -0.88 a share.

Past results

Reported against what analysts expected

30 Sept 202411 Sept 202413 May 202411 Mar 202415 Nov 20239 Aug 2023
Earnings per share-0.39-0.39-0.50-1.45-5.20-4.08
Forecast-0.30-0.30-0.43-0.88——

Key events

  1. 31 Oct 202317-to-1 reverse split
  2. 19 Aug 2022Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.